Direct acting oral anticoagulants are more effective than Vitamin-K-antagonists for the resolution of established left atrial thrombi in patients with atrial fibrillation

被引:0
|
作者
Hammerstingl, C. [1 ]
Lambers, M. [1 ]
Schueler, R. [1 ]
Momcilovic, D. [1 ]
Oetztuerk, C. [1 ]
Nickenig, G. [1 ]
机构
[1] Univ Bonn, Bonn, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P5528
引用
下载
收藏
页码:994 / 994
页数:1
相关论文
共 50 条
  • [21] Women with atrial fibrillation benefit more than men from direct acting oral anticoagulants (DOAC)
    Colquhoun, D.
    Cross, D.
    Amerena, J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 513 - 514
  • [22] Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation
    Orenes-Pinero, Esteban
    Esteve-Pastor, Maria A.
    Valdes, Mariano
    Lip, Gregory Y. H.
    Marin, Francisco
    DRUG DISCOVERY TODAY, 2017, 22 (10) : 1565 - 1571
  • [23] Direct oral anticoagulants compared to vitamin K antagonists for the treatment of left ventricular thrombi
    Morgan, H.
    Jones, J.
    Rathod, K.
    O'Dowling, R.
    Pieri, C.
    Antoniou, S.
    Mathur, A.
    Perera, D.
    Jones, D.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2714 - 2714
  • [24] Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi
    Saleh, Yehia
    Al-abcha, Abdullah
    Abdelkarim, Ola
    Abdelnabi, Mahmoud
    Almaghraby, Abdallah
    Kleiman, Neal S.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) : 231 - 238
  • [25] Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi
    Yehia Saleh
    Abdullah Al-abcha
    Ola Abdelkarim
    Mahmoud Abdelnabi
    Abdallah Almaghraby
    Neal S. Kleiman
    American Journal of Cardiovascular Drugs, 2022, 22 : 231 - 238
  • [26] Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
    Li, Wenhao
    Zhou, Yanxia
    Chen, Siqi
    Zeng, Dewang
    Zhang, Haidong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [27] Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: A meta-analysis
    Yokoyama, Yujiro
    Briasoulis, Alexandros
    Ueyama, Hiroki
    Mori, Makoto
    Iwagami, Masao
    Misumida, Naoki
    Takagi, Hisato
    Kuno, Toshiki
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 165 (06): : 2052 - +
  • [28] Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation
    Saliba, Layla
    Mondoly, Pierre
    Duparc, Alexandre
    Bura-Riviere, Alessandra
    Maury, Philippe
    Calmels, Violaine
    Sallerin, Brigitte
    Pathak, Atul
    Montastruc, Jean-Louis
    Bagheri, Haleh
    THERAPIE, 2015, 70 (06): : 485 - 492
  • [29] Clearing the cognitive cloud: direct oral anticoagulants or vitamin K antagonists for reducing dementia risk in patients with atrial fibrillation?
    Chua, Winnie
    HEART, 2021, 107 (23) : 1854 - 1855
  • [30] Meta-Analysis of Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Valves
    Yokoyama, Yujiro
    Briasoulis, Alexandros
    Ueyama, Hiroki
    Mori, Makoto
    Iwagami, Masao
    Misumida, Naoki
    Takagi, Hisato
    Kuno, Toshiki
    CIRCULATION, 2021, 144